The present invention provides a SPARK-seq high-
throughput platform for the identification and
kinetics analysis of
nucleic acid aptamers and target proteins thereof. By combining
cell screening,
CRISPR gene perturbation and single-
cell multi-
omics sequencing technology, the platform enables systematic identification of the interaction between thousands of
nucleic acid aptamers and target proteins thereof in a single experiment; in addition, high-
throughput screening of high-stability
nucleic acid aptamers having "slow dissociation" characteristics is achieved on the basis of dissociation
kinetics. The method provided by the present invention overcomes the limitations of the traditional technology of low
throughput, difficulty in identifying targets having relatively low abundance, and inability to perform efficiently screening in natural
cell environments, not only achieves large-scale and unbiased discovery of
aptamer targets, but also can accurately screen high-stability aptamers having slow dissociation rates, providing more powerful molecular tools and new
biomarker discovery pathways for tumor diagnosis,
targeted therapy, and accurate
medical treatment.